Man Group’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$585K Buy
+16,152
New +$474K ﹤0.01% 2019
2026
Q1
– Sell
-10,473
Closed -$177K – 2448
2025
Q4
$177K Sell
10,473
-2,176
-17% -$38.3K ﹤0.01% 2143
2025
Q3
$275K Sell
12,649
-11,105
-47% -$184K ﹤0.01% 2034
2025
Q2
$338K Buy
23,754
+1,350
+6% +$21.3K ﹤0.01% 1934
2025
Q1
$291K Buy
+22,404
New +$339K ﹤0.01% 1942

Other funds holding ETON

Man Group's ETON Position: Q2 2026 in Review

Man Group opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 16,152 shares worth $585K. The stake represents ﹤0.01% of the portfolio and ranks #2019 among its holdings. This is a return to the name: Man Group previously reported a position in ETON as recently as Q4 2025.

Man Group first reported a position in ETON in Q1 2025 and has held it in 5 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Man Group held 16,152 shares of Eton Pharmaceutcials worth $585K as of Q2 2026.
  • Eton Pharmaceutcials was a new Man Group position in Q2 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2019 holding.
  • Man Group first reported a position in Eton Pharmaceutcials in Q1 2025 and has held it in 5 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.